iCardiac Technologies

Location: Rochester, New York

Sub-headline: Status: Acquired

Main Description:

iCardiac Technologies is a leading provider of advanced cardiac safety analysis technologies. The company develops and implements advanced ECG-based cardiac safety biomarkers and tools. iCardiac provides drug developers with more precise and cost-effective methods for QT interval measurement. In addition, it provides a suite of advanced ECG-based cardiac safety markers that deliver a more accurate assessment of the cardiac safety profile of drugs in development.

Stonehenge exited its investment in iCardiac, when Norwest Venture Partners acquired a controlling interest in the spring of 2014.

Css Class: iCardiac

Category: Select Past Investments